Hong Kong-listed WuXi Biologics falls as co sells Irish vaccine facility

WuXi Biologics (Cayman)

07/01/2025 02:38

** Shares of China's WuXi Biologics  2269.HK  fall 5.9% to
HK$15.62, on track for their biggest one-day pct drop since Oct
15 if current losses hold
    ** Stock hits the lowest level since Dec 3 on its second
straight session of decline; second-biggest pct loser in the
Hang Seng Index  .HSI , which slips 0.6%
    ** Co said on Monday it would sell its vaccine facility in
Ireland to U.S. drugmaker Merck & Co  MRK.N  for about $500 mln,
ahead of potential U.S. legislation that would restrict business
for Chinese biotech companies
    ** The U.S. House of Representatives passed the Biosecure
Act in September, which would ban federal contracts with
targeted firms and their business partners
    ** The Hang Seng Commerce & Industry Index  .HSNC  eases
0.8% and the healthcare index  .HSCIH  declines 0.7%
    

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))